Doyle; Anthony G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Doyle; Anthony G..The latest application filed is for "antibodies that specifically bind to tl1a".
- Doyle; Anthony G. - Macquarie Park AU
- Doyle; Anthony G. - Drummoyne AU
| Patent | Date |
|---|---|
| Antibodies That Specifically Bind To TL1A App 20220185902 - POULTON; Lynn Dorothy ; et al. | 2022-06-16 |
| Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases Grant 11,220,549 - Poulton , et al. January 11, 2 | 2022-01-11 |
| Fusions of antibodies to CD38 and attenuated interferon alpha Grant 10,981,986 - Wilson, Jr. , et al. April 20, 2 | 2021-04-20 |
| Antibodies That Specifically Bind To TL1A App 20190106486 - Poulton; Lynn Dorothy ; et al. | 2019-04-11 |
| Antibodies that specifically bind to TL1A Grant 10,138,296 - Poulton , et al. Nov | 2018-11-27 |
| Fusions Of Antibodies To Cd38 And Attenuated Interferon Alpha App 20170233449 - Wilson, Jr.; David S. ; et al. | 2017-08-17 |
| Fusions of antibodies to CD38 and attenuated interferon alpha Grant 9,611,322 - Wilson, Jr. , et al. April 4, 2 | 2017-04-04 |
| Antibodies That Specifically Bind To Tl1a App 20170081400 - Poulton; Lynn Dorothy ; et al. | 2017-03-23 |
| Polypeptide Constructs And Uses Thereof App 20160367695 - Wilson; David S. ; et al. | 2016-12-22 |
| Anti-IL-23 heterodimer specific antibodies Grant 9,127,057 - Clarke , et al. September 8, 2 | 2015-09-08 |
| Treatment of cancer involving mutated KRAS or BRAF genes Grant 8,932,588 - Kienzle , et al. January 13, 2 | 2015-01-13 |
| Humanized antibodies with anti-tumor activity Grant 8,901,279 - Clarke , et al. December 2, 2 | 2014-12-02 |
| Polypeptide Constructs And Uses Thereof App 20140248238 - Wilson, JR.; David S. ; et al. | 2014-09-04 |
| Humanized Antibodies with Anti-Tumor Activity App 20130280246 - Clarke; Adam W. ; et al. | 2013-10-24 |
| Humanised antibodies with anti-tumour activity Grant 8,470,320 - Clarke , et al. June 25, 2 | 2013-06-25 |
| Anti-il-23 Heterodimer Specific Antibodies App 20130115166 - Clarke; Adam William ; et al. | 2013-05-09 |
| Nucleic acid molecules encoding anti-inflammatory domain antibodies App 20130040383 - Woolven; Benjamin P. ; et al. | 2013-02-14 |
| Treatment of Cancer Involving Mutated KRAS or BRAF Genes App 20120244151 - Kienzle; Norbert A. ; et al. | 2012-09-27 |
| Anti-inflammatory dAb Grant 8,263,076 - Woolven , et al. September 11, 2 | 2012-09-11 |
| Anti-inflammatory Dab App 20110237780 - Woolven; Benjamin P. ; et al. | 2011-09-29 |
| Anti-inflammatory dAb Grant 7,981,414 - Woolven , et al. July 19, 2 | 2011-07-19 |
| Domain Antibody Construct App 20110044979 - DOYLE; Anthony G. ; et al. | 2011-02-24 |
| Domain antibody construct Grant 7,846,439 - Doyle , et al. December 7, 2 | 2010-12-07 |
| Humanised Antibodies With Anti-tumour Activity App 20100297134 - Clarke; Adam W. ; et al. | 2010-11-25 |
| Chimeric Antibodies With Part New World Primate Binding Regions App 20090286962 - Woolven; Benjamin P. ; et al. | 2009-11-19 |
| Anti-inflammatory dab App 20090226428 - Woolven; Benjamin P. ; et al. | 2009-09-10 |
| Chimeric Antibodies App 20080255343 - JENNINGS; Philip A. ; et al. | 2008-10-16 |
| Chimeric antibodies App 20080139790 - Jennings; Philip A. ; et al. | 2008-06-12 |
| Engineered Antibodies With New World Primate Framework Regions App 20080095767 - JENNINGS; Philip A. ; et al. | 2008-04-24 |
| Domain Antibody Construct App 20070202105 - DOYLE; ANTHONY G. ; et al. | 2007-08-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 